AL Amyloidosis Diagnostic Market is driven by disease prevalence

a adăugat un sunet Health

2025-06-16 09:49:38 -

The AL Amyloidosis Diagnostic Market comprises innovative assays, imaging modalities, and biomarker-based tests designed to detect light-chain amyloid deposits in tissues and organs. Products include mass spectrometry platforms, immunohistochemistry kits, cardiac MRI, and novel blood‐based biomarkers, each offering high sensitivity, rapid turnaround times, and minimally invasive sampling. These...

0 Commentarii 0 Distribuiri 14 Views 0 previzualizare